The vast increase in Alzheimer disease (AD) worldwide has grave implications for
individuals, family support systems and the health-care systems that will attempt to cope with …

Topic OCT is a noninvasive tool to measure specific retinal layers in the eye. The
relationship of retinal spectral-domain (SD) OCT measurements with Alzheimer's disease …

Introduction Retinal characteristics are increasingly recognized as biomarkers for
neurodegenerative diseases. Retinal thickness measured by optical coherence tomography …

Retinal imaging technology is rapidly advancing and can provide ever-increasing amounts
of information about the structure, function and molecular composition of retinal tissue in …

Background Retinal changes may reflect the pathophysiological processes in the central
nervous system and can be assessed by imaging modalities non-invasively. We aim to …

Abstract Background Patients with Parkinson's disease experience visual symptoms,
partially originating from retinal changes. Since 2011, multiple case-control studies using …

Over the past decade, a surge of evidence has documented various pathological processes
in the retina of patients suffering from mild cognitive impairment, Alzheimer's disease (AD) …

Many neurodegenerative disorders, such as Parkinson's disease (PD) and Alzheimer's
disease (AD), are characterized by loss of retinal ganglion cells (RGCs) as part of the …

Introduction We conducted a 27-month longitudinal study of mid-life adults with preclinical
Alzheimer's disease (AD), using spectral domain optical coherence tomography to compare …

Background To explore the retinal vascular density changes in Alzheimer's disease (AD)
and mild cognitive impairment (MCI) patients using optical coherence tomography …